Brakel

Researchers are evaluating the midterm clinical performance and safety of the redesigned Unicompartmental Univation® XF Pro knee implant in patients with gonarthritis and degenerative disease. This prospective, observational study aims to collect clinical data from 150 patients across four centers in Germany, focusing on the routine use of the device according to authorized instructions. Participants will receive the Univation® XF Pro implant as a primary medial unicompartmental knee arthroplasty. The study observes the implant's use in standard clinical practice without additional experimental procedures. Data collection will be done electronically to document safety and performance during routine follow-up. Participants will be followed for up to five years after surgery to assess functional outcomes reported by patients. Clinical data, including safety and performance measures, will be monitored and recorded using electronic case report forms. The study focuses on midterm results, aiming to understand how well the implant performs and its safety profile over time.